Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Insights from 8 Years of adoption experience of transcatheter mitral valve repair in Germany: Observed utilization patterns and impact on overall mitral valve procedure volumes.

Schaefer A, Lubos E, Pietzsch JB, Pietzsch M, Weber S, Blankenberg S, Reichenspurner H, Schäfer U, Conradi L.

EuroIntervention. 2018 Aug 14. pii: EIJ-D-18-00403. doi: 10.4244/EIJ-D-18-00403. [Epub ahead of print]

2.

Should Surgical Repair Be Recommended Over Nonoperative Management for Medial Meniscus Root Tears? Response.

Faucett SC, Geisler BP, Chahla J, Krych AJ, LaPrade RF, Pietzsch JB.

Am J Sports Med. 2018 Jul;46(9):NP44-NP45. doi: 10.1177/0363546518783956. No abstract available.

PMID:
30011253
3.

Changes in medication cost observed in chronic cluster headache patients treated with sphenopalatine ganglion (SPG) stimulation: Analysis based on 1-year data from the Pathway R-1 Registry.

Pietzsch JB, Weber SA, Lund N, Gaul C.

Cephalalgia. 2018 Jul;38(8):1455-1462. doi: 10.1177/0333102418784689. Epub 2018 Jun 19.

PMID:
29921140
4.

Sex differences in discharge destination following acute myocardial infarction.

Perl L, Peiffer V, Fuhrer AE, D'Ascenzo F, Pietzsch JB.

Coron Artery Dis. 2018 Sep;29(6):502-510. doi: 10.1097/MCA.0000000000000643.

PMID:
29878902
5.

Meniscus Root Repair vs Meniscectomy or Nonoperative Management to Prevent Knee Osteoarthritis After Medial Meniscus Root Tears: Clinical and Economic Effectiveness.

Faucett SC, Geisler BP, Chahla J, Krych AJ, Kurzweil PR, Garner AM, Liu S, LaPrade RF, Pietzsch JB.

Am J Sports Med. 2018 Mar 1:363546518755754. doi: 10.1177/0363546518755754. [Epub ahead of print]

PMID:
29517925
6.

Correction to: Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan.

Pietzsch JB, Geisler BP, Ikeno F.

Cardiovasc Interv Ther. 2017 Oct 27. doi: 10.1007/s12928-017-0492-7. [Epub ahead of print]

PMID:
29080193
7.

Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan.

Pietzsch JB, Geisler BP, Ikeno F.

Cardiovasc Interv Ther. 2017 Sep 5. doi: 10.1007/s12928-017-0488-3. [Epub ahead of print]

PMID:
28875395
8.

Response to Lee et al.

Feller-Kopman D, Liu S, Geisler BP, DeCamp MM, Pietzsch JB.

J Thorac Oncol. 2017 Sep;12(9):e152-e153. doi: 10.1016/j.jtho.2017.07.002. No abstract available.

PMID:
28838721
9.

Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.

Feller-Kopman D, Liu S, Geisler BP, DeCamp MM, Pietzsch JB.

J Thorac Oncol. 2017 Aug;12(8):1223-1232. doi: 10.1016/j.jtho.2017.04.030. Epub 2017 May 11.

10.

Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.

Pietzsch JB, Garner AM, Marks WJ Jr.

Neuromodulation. 2016 Oct;19(7):689-697. doi: 10.1111/ner.12474. Epub 2016 Aug 5.

PMID:
27491661
11.

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

Katsanos K, Geisler BP, Garner AM, Zayed H, Cleveland T, Pietzsch JB.

BMJ Open. 2016 May 9;6(5):e011245. doi: 10.1136/bmjopen-2016-011245. Review.

12.

The cost-effectiveness of meniscal repair versus partial meniscectomy: A model-based projection for the United States.

Feeley BT, Liu S, Garner AM, Zhang AL, Pietzsch JB.

Knee. 2016 Aug;23(4):674-80. doi: 10.1016/j.knee.2016.03.006. Epub 2016 May 3.

PMID:
27157145
13.

Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome.

Noblett KL, Dmochowski RR, Vasavada SP, Garner AM, Liu S, Pietzsch JB.

Neurourol Urodyn. 2017 Mar;36(3):727-733. doi: 10.1002/nau.23008. Epub 2016 Apr 6.

PMID:
27062384
14.

Economic Study Design for the Optimize Study on Orbital Atherectomy and Drug-Coated Balloon Devices for the Treatment of Below-The-Knee Peripheral Arterial Disease.

Martinsen BJ, Weber SA, Pietzsch ML, Behrens A, Weatherspoon M, Igyarto Z, Zhao R, Kotlarz H, Pietzsch JB.

Value Health. 2015 Nov;18(7):A723. doi: 10.1016/j.jval.2015.09.2745. Epub 2015 Oct 20. No abstract available.

15.

Adoption Of Transcatheter Aortic Valve Replacement In Germany: Utilization Patterns And Case Volumes Compared To Surgical Aortic Valve Replacement In The Period 2009-2013.

Pietzsch JB, Busca R, Geisler BP.

Value Health. 2015 Nov;18(7):A370. doi: 10.1016/j.jval.2015.09.747. Epub 2015 Oct 20. No abstract available.

16.

The Impact Of New Endovascular Therapies For Femoropopliteal Arterial Disease On Therapy Utilization And Case Volumes In Germany, 2009-2013.

Pietzsch JB, Weber SA, Pietzsch ML, Zeller T.

Value Health. 2015 Nov;18(7):A366. doi: 10.1016/j.jval.2015.09.728. Epub 2015 Oct 20. No abstract available.

17.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement: Current Decision-Analytic Models and Future Opportunities.

Busca R, Geisler BP, Pietzsch JB.

Value Health. 2015 Nov;18(7):A359. doi: 10.1016/j.jval.2015.09.686. Epub 2015 Oct 20. No abstract available.

18.

Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease: Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence.

Pietzsch JB, Geisler BP, Zeller T.

Value Health. 2015 Nov;18(7):A349. doi: 10.1016/j.jval.2015.09.632. Epub 2015 Oct 20. No abstract available.

19.
20.

Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany.

Conradi L, Lubos E, Treede H, Pietzsch JB, Weber S, Pietzsch M, Overlack K, Diemert P, Blankenberg S, Reichenspurner H.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1114-9. doi: 10.1002/ccd.25962. Epub 2015 Apr 28.

PMID:
25918878
21.

Cost-Effectiveness of Endobronchial Valve Therapy for Severe Emphysema: A Model-Based Projection Based on the Vent Study.

Pietzsch JB, Garner AM, Herth FJ.

Value Health. 2014 Nov;17(7):A598. doi: 10.1016/j.jval.2014.08.2068. Epub 2014 Oct 26. No abstract available.

22.

Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension: Impact Of Age And Cardiovascular Risk Factors.

Pietzsch JB, Geisler BP, Esler MD.

Value Health. 2014 Nov;17(7):A474. doi: 10.1016/j.jval.2014.08.1354. Epub 2014 Oct 26. No abstract available.

23.

Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial.

Pietzsch JB, Liu S, Garner AM, Kezirian EJ, Strollo PJ.

Sleep. 2015 May 1;38(5):735-44. doi: 10.5665/sleep.4666.

24.

Cost-effectiveness of endobronchial valve therapy for severe emphysema: a model-based projection based on the VENT study.

Pietzsch JB, Garner A, Herth FJ.

Respiration. 2014;88(5):389-98. doi: 10.1159/000368088. Epub 2014 Sep 30.

25.

Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.

Pietzsch JB, Geisler BP, Garner AM, Zeller T, Jaff MR.

Catheter Cardiovasc Interv. 2014 Oct 1;84(4):546-54. doi: 10.1002/ccd.25536. Epub 2014 May 27. Review.

PMID:
24782424
26.

Outcomes from a postgraduate biomedical technology innovation training program: the first 12 years of Stanford Biodesign.

Brinton TJ, Kurihara CQ, Camarillo DB, Pietzsch JB, Gorodsky J, Zenios SA, Doshi R, Shen C, Kumar UN, Mairal A, Watkins J, Popp RL, Wang PJ, Makower J, Krummel TM, Yock PG.

Ann Biomed Eng. 2013 Sep;41(9):1803-10. doi: 10.1007/s10439-013-0761-2. Epub 2013 Feb 13.

27.

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB.

J Am Coll Cardiol. 2012 Oct 2;60(14):1271-7. doi: 10.1016/j.jacc.2012.07.029. Epub 2012 Sep 12.

28.

An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.

Pietzsch JB, Garner A, Cipriano LE, Linehan JH.

Sleep. 2011 Jun 1;34(6):695-709. doi: 10.5665/SLEEP.1030.

29.

Toward a 21st-century health care system: recommendations for health care reform.

Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Jost TS, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Luft HS, Mashal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Silber BM, Skinner J, Shortell SM, Thier SO, Tunis S, Wulsin L Jr, Yock P, Nun GB, Bryan S, Luxenburg O, van de Ven WP.

Ann Intern Med. 2009 Apr 7;150(7):493-5. Epub 2009 Mar 2.

PMID:
19258550
30.

Bayesian assessment of overtriage and undertriage at a level I trauma centre.

DiDomenico PB, Pietzsch JB, Paté-Cornell ME.

Philos Trans A Math Phys Eng Sci. 2008 Jul 13;366(1874):2265-77. doi: 10.1098/rsta.2008.0036.

31.

Early technology assessment of new medical devices.

Pietzsch JB, Paté-Cornell ME.

Int J Technol Assess Health Care. 2008 Winter;24(1):36-44. doi: 10.1017/S0266462307080051.

PMID:
18218167
32.

Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.

Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, Garber AM.

Pediatrics. 2002 Sep;110(3):471-80.

PMID:
12205247
33.

[Conditions and success factors of telemedicine innovation].

Pietzsch JB, Gemuenden HG, Bolz A.

Biomed Tech (Berl). 2001 Apr;46(4):96-100. German.

PMID:
11388041

Supplemental Content

Loading ...
Support Center